Autoimmune disease: Latest News, Top Stories & Analysis

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has released positive preliminary clinical data from its Phase 1/2 trials of CABA-201, a new potential treatment option for patients with autoimmune …

Products and Services

YPrime Introduces Innovative Assessment Tool to Enhance Clinical Trials for Autoimmune Diseases

April 30, 2024April 30, 2024 - by Timothy Alexander

MALVERN, PA — YPrime has unveiled its latest innovation, the Tender Swollen Joint Count (TSJC) assessment. This tool is designed to revolutionize the way disease activity affecting joints is measured …